Fuzzy Panda Research short ‘last COVID over-earning’ Stride

In a recently published report, Fuzzy Panda Research says it is short Stride as it believes the K-12 online education company is the last COVID “over-earning stock yet to fall.” “The stock is near its highs but investors are clueless about the looming COVID funding cliff. Investors don’t know because Stride management has NOT told them. Instead, management has said over and over again that the company received little to no benefit from the $190 Billion of federal COVID funds. Former Stride executives told us that management misled investors,” the report reads. “Now that the ESSER Covid funds are finally ending, investors are set to find out the truth,” it adds.